Hepatitis B Virus Therapy
Reports on hepatitis B virus therapy findings from National Cheng-Kung University, Medical College provide new insights
Published in Medical Verdicts and Law Weekly, November 5th, 2009
Research findings, 'Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naive HBeAg-positive patients with chronic hepatitis B,' are discussed in a new report. According to recent research from Tainan, Taiwan, "Entecavir is a potent inhibitor of hepatitis B virus (HBV) polymerase. The efficacy and safety of entecavir in nucleoside-naive patients with hepatitis B virus e antigen (HBeAg)-positive chronic hepatitis B was established in a large, international, double-dummy study (ETV-022) where patients were randomized to entecavir 0.5 mg/day (n=354) or lamivudine 100 mg/day (n=355) once daily."
"ETV-022 had a 52-week blinded treatment phase, followed...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- AARP Maryland
AARP Maryland Key Vote News Alert - Acacia Research Corporation
Acacia Subsidiary Enters into License Agreement with PNC Financial Services Group, Inc. - Agency for Healthcare Research & Quality
Patient Safety and Medical Liability Reform Subcommittee Meeting - AIDS Healthcare Foundation
Congress Enacts AIDS Bill to Test 5 Million; AHF Urges President Obama to Act Swiftly - American Federation of Government Employees
TSA Union to Celebrate Miami TSA Workers with Friday Event - American Scientific Resources, Inc.
American Scientific Resources Announces Addition of New Board Member - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
